A carregar...
Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature
This Mini Review of the literature aimed to assess the role of tocilizumab for the treatment of severe coronavirus disease 2019 (COVID-19). Based on the available scientific evidence, it is not clear to date what is the best therapeutic strategy for the treatment of COVID-19. Since SARS-CoV-2 infect...
Na minha lista:
| Publicado no: | Biochem Biophys Res Commun |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7699161/ https://ncbi.nlm.nih.gov/pubmed/33303188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbrc.2020.11.084 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|